- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06228716
Education With Hybrid Simulation Method in Patients Administering Subcutaneous Biological Drugs
The Effect of the Training Given by Hybrid Simulation Method on The Skill and Anxiety Level of the Patients Applying Subcutaneous Biological Drugs
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A poor self-injection experience can lead to undesirable treatment outcomes. However, increasing morbidity and mortality rates are closely related to non-adherence to treatment. Undesirable results due to non-compliance with treatment lead to more visits to emergency services, prolongation of inpatient treatments and increased surgical interventions, thus increasing the workload and costs of health services. In addition, patients who cannot receive repeated and effective training on subcutaneous injection application cause them to experience anxiety about subcutaneous drug administration on their own, and often come to health units only for subcutaneous injection, due to the limited ability to administer. This situation can both negatively affect the daily life activities and self-efficacy perceptions of the patients and increase the workload and cost in health services.
Hybrid Simulation; It is also defined as "patient-centered simulation". In this method; Simulated/standardized patient method is used together with auxiliary tools. Wearable simulation tools are used in this simulation type. When the literature is examined, it is seen that various training methods for self-administration skills are used in patients followed in the rheumatology outpatient clinic, but their effectiveness is controversial. In addition, no study has been found to evaluate the effectiveness of a hybrid simulation-based training on the improvement of application skills and reduction of anxiety regarding subcutaneous injection of biologic drugs, for which adherence to treatment is vital. The aim of this study is to evaluate the effect of training given by simulation method on patients who administer subcutaneous biologic drugs on their application skills and anxiety level. It is thought that these patients, who are trained with the hybrid simulation method, will decrease their negative experiences of subcutaneous biologic drug administration by repetitive applications and incorrect drug administration due to misunderstandings, their injection administration skills will improve, and their anxiety about injection will decrease.
Purpose and Design of the Research
This study was planned in a pre-test-post-test randomized controlled design in order to evaluate the effect of the training given by the hybrid simulation method to the patients who administered subcutaneous biologic drugs on the application skill and anxiety level.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
İ̇stanbul
-
Üsküdar, İ̇stanbul, Turkey
- University of Health Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Being between the ages of 18-50,
- Residing in Istanbul,
- Their family/relatives are not using medication in subcutaneous injection form,
- Receiving injection training for the first time,
- First time injection application,
- Using biological medication for the first time,
- Using subcutaneous biological medication for the first time,
- The requested subcutaneous biological drug must be in pen form,
- The drug administration dose should be once every 2 weeks (1/14),
- Being open to communication and cooperation,
- No experience of injecting any living creature (human or animal),
- There is no cognitive, perceptual, or physical disability that would hinder the ability to administer self-injection,
- Volunteering to participate in the research.
Exclusion Criteria:
- Leaving the study at any stage of the research process,
- Not participating in the training and evaluations included in the research,
- Having any local or systemic infectious disease at any stage of the research process.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental
Subcutaneous biological drug self-administration training was given by the researcher in two stages, theoretical and practical, face to face.
Power point presentation and training brochure were used in theoretical training.
The practical training given after the theoretical training was given using the Hybrid simulation method.
The Wearable Subcutaneous Injection Hybrid Simulator developed by the researcher was worn by the individuals after being informed about its purpose and function.
A medicine pen similar to their own medicine pens (demo pen without medicine), dry cotton, alcohol swab (similar to the ones that come in medicine pen boxes), and a small notepad and pen were left in a clean medicine tray on a clean table.
Afterwards, they were expected to apply the subcutaneous application step by step as explained to them.
Each application step they made incorrectly was corrected and repeated with the support of the researcher.The training took approximately 40 minutes.
|
Subcutaneous biological drug self-administration training was given by the researcher in two stages, theoretical and practical, face to face.
Power point presentation and training brochure were used in theoretical training.
The practical training given after the theoretical training was given using the Hybrid simulation method.
The Wearable Subcutaneous Injection Hybrid Simulator developed by the researcher was worn by the individuals after being informed about its purpose and function.
Afterwards, they were expected to apply the subcutaneous application step by step as explained to them.
Each application step they made incorrectly was corrected and repeated with the support of the researcher.
The application was considered successful if they completed all application steps correctly from start to finish.
The training took approximately 40 minutes.
After the practical training, the individuals' questions, if any, were answered and the training was terminated.
|
Other: Kontrol Group
Subcutaneous biological drug self-administration training was given theoretically face to face by the researcher using a power point presentation and training brochure.
The training lasted approximately 25 minutes and was given in the same room where the experimental group received training.
|
Subcutaneous biological drug self-administration training was given theoretically face to face by the researcher using a power point presentation and training brochure.
The training lasted approximately 25 minutes and was given in the same room where the experimental group received training.
After the training, any questions the individuals had were answered and the training was ended.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Information Form
Time Frame: Before training
|
It was structured by the researcher in line with the literature and included demographic information such as "the individual's name, surname, age, gender, marital status, education level" as well as "medical diagnosis, the name of the subcutaneous medication used and whether he/she has received any simulation-based training before and his phone number."
It consisted of 11 questions including ".
|
Before training
|
Determination of state anxiety level/pretest application
Time Frame: Before training and 2. week before first self administration of subcutaneous injection by the patient
|
All individuals in both the experimental and control groups included in the sample were asked to fill out the State Anxiety Scale to evaluate their anxiety levels before the subcutaneous biological drug administration training.
|
Before training and 2. week before first self administration of subcutaneous injection by the patient
|
Subcutaneous Biological Drug Self-Administration Skill Checklist
Time Frame: 1. week post training; 2. week post training
|
Checklist consisting of 20 application steps to evaluate the skill level of Subcutaneous Biological Drug Self-Administration
|
1. week post training; 2. week post training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Subcutaneous Biological Drug Knowledge Test
Time Frame: 1. week post training
|
17-item test assessing the level of knowledge about subcutaneous biological drugs
|
1. week post training
|
Patient Education Evaluation Survey
Time Frame: 1. week post training
|
5-point Likert-type survey consisting of 10 items on patients' evaluation of education
|
1. week post training
|
Trait anxiety scale
Time Frame: 1. week post training
|
20-item scale assessing an individual's trait anxiety.
trait anxiety scale
|
1. week post training
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: İlayda Türkoğlu, Saglik Bilimleri Universitesi
Publications and helpful links
General Publications
- Stenger F, Konig A, Ochsendorf F, Kaufmann R, Pinter A. Correct performance of subcutaneous injections in plaque psoriasis: comparison of trained and untrained patients with different application systems in routine clinical care. J Dermatolog Treat. 2021 Dec;32(8):898-906. doi: 10.1080/09546634.2020.1720580. Epub 2020 Feb 2.
- Timmermann H, Mailander C. Home Self-Administration of Biologics - A German Survey among Omalizumab-Treated Patients with Severe Asthma and their Treating Physicians. Pneumologie. 2020 Feb;74(2):103-111. doi: 10.1055/a-1069-0900. Epub 2020 Jan 9.
- Fischer-Cartlidge E, Romanoff S, Thom B, Burrows Walters C. Comparing Self-Injection Teaching Strategies for Patients With Breast Cancer and Their Caregivers: A Pilot Study. Clin J Oncol Nurs. 2016 Oct 1;20(5):515-21. doi: 10.1188/16.CJON.515-521.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 10840098-772.02-E.60612
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Training
-
Temple UniversityNational Cancer Institute (NCI)CompletedStandard Training | Online TrainingUnited States
-
Methodist University, North CarolinaUnknownResistance Training With Traditional Periodization Model | Resistance Training With Conjugate Training ModelUnited States
-
Rigshospitalet, DenmarkCompletedSimulation-based Ultrasound Training, Error-management Training, Training With Errors, Skills TransferDenmark
-
Klinik für Allgemein- und Viszeralchirurgie, Department...WithdrawnLaparoscopy Training | Robotic Surgery TrainingSwitzerland
-
Riphah International UniversityRecruitingIntegrated Resisted Training | Isolated Resised TrainingPakistan
-
University in Zielona GóraPoznan University of Physical EducationCompletedTraditional Strength Training vs Inertial TrainingPoland
-
University of MiamiCompletedResistance Training | High-Intensity Interval TrainingUnited States
-
The University of Hong KongCompletedMindfulness | Parent Management Training | Mindful Parenting TrainingHong Kong
-
Inland Norway University of Applied SciencesCompletedHeat-suit Endurance Training | Non-heat-suit Endurance TrainingNorway
-
Ayse BahaCompletedCOPD | Inhaler Training | Face-to-face Training | Video-mediated Virtual TrainingTurkey
Clinical Trials on Training with hybrid simulation method
-
Akdeniz UniversityCompleted
-
Bitlis Eren UniversityCompleted
-
Zonguldak Bulent Ecevit UniversityNurten Taşdemir Assoc. Prof. PhD.UnknownCardiopulmonary Resuscitation | Nurse's Role | Simulation TrainingTurkey
-
American University of Beirut Medical CenterCompletedMedical Education | Clinical Breast Examination | Medical Simulation | Standardized PatientLebanon
-
Ege UniversityCompleted
-
Mbarara University of Science and TechnologyUniversity of CalgaryUnknownMaternal Health | Newborn; VitalityUganda
-
Tokat Gaziosmanpasa UniversityCompleted
-
Saglik Bilimleri UniversitesiCompleted
-
University of Kansas Medical CenterKurume UniversityCompleted